Mohinder Gupta
Internal Medicine · Flushing, NYNPI 1659337285
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 490 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 12.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $5,301 and has fallen 85.4% since, to $773 in 2025. Among internal medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 490 payments — averaging $45.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$3K
- Medtronic$3K
- Boehringer Ingelheim$2K
- Johnson & Johnson$2K
- Boston Scientific$2K
- AstraZeneca$1K
- plus $9K from 29 others
What the payments were for
- Food & beverage$22,124100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 44 | $2,753 |
| Medtronic(2 entities) | 21 | $2,694 |
| Boehringer Ingelheim | 37 | $2,441 |
| Johnson & Johnson | 47 | $2,174 |
| Boston Scientific | 42 | $1,935 |
| AstraZeneca | 35 | $1,420 |
| Pfizer | 46 | $1,344 |
| Merck | 35 | $949 |
| Abbott | 13 | $923 |
| Novartis | 39 | $881 |
| Amgen | 21 | $685 |
| Esperion Therapeutics, Inc. | 19 | $582 |
| Edwards Lifesciences | 16 | $563 |
| W. L. Gore & Associates, Inc. | 10 | $464 |
| Sanofi-aventis U.S. LLC | 3 | $365 |
| Bayer | 8 | $272 |
| E.r. Squibb & Sons, L.L.C. | 10 | $230 |
| Scpharmaceuticals Inc. | 7 | $187 |
| Arbor Pharmaceuticals, Inc. | 10 | $160 |
| Cequr Corporation | 1 | $140 |
| Lexicon Pharmaceuticals, Inc. | 5 | $129 |
| Dexcom, Inc. | 1 | $125 |
| GSK | 1 | $125 |
| Intuity Medical Inc | 1 | $124 |
| Gilead | 1 | $84 |
| Alnylam Pharmaceuticals Inc. | 3 | $77 |
| Regeneron Healthcare Solutions, Inc. | 3 | $73 |
| Kowa Pharmaceuticals America, Inc. | 4 | $61 |
| Kestra Medical Technology Services, Inc. | 1 | $43 |
| Heartflow, Inc. | 1 | $25 |
| Abiomed | 1 | $23 |
| Biotronik Inc. | 1 | $22 |
| Baxter Healthcare | 1 | $19 |
| Akcea Therapeutics, Inc. | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$1,872
- JARDIANCE$1,826
- XARELTO$1,435
- COBALT DR MRI SURESCAN$663
- FARXIGA$624
- Watchman$472
- AURORA EV-ICD MRI SURESCAN$455
- Claria MRI$385
- PRALUENT$365
- ELIQUIS$357
- PERCEPTA QUAD CRT-P MRI SURESCAN$314
- Confirm Rx$305
- Micra$294
- WATCHMAN Access System$272
- BREZTRI$250
- VERQUVO$249
- NEXLIZET$249
- NEXLETOL$249
- Repatha$238
- LUX-DX$235
How this compares
$22,124 in reported general payments places this provider in the 95th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in Flushing
- Weining LiangFlushing$133K
- David DoveEast Hampton$12.3M
- Bruce BergerBrooklyn$3.4M
- Nicholas RobinsonBuffalo$2.9M
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Scott BeegleAlbany$1.9M
- Anthony MartinezBuffalo$1.6M
- Javier MoralesGreenvale$1.3M
- Ricky HsuNew York$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.